This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Herniorrhaphy Is A Surgical Procedure Used To Repair A Hernia, Which Is A Hole Or Weak Spot In The Abdominal Wall That Allows The Contents Of The Abdomen To Protrude Through. Hernias Can Be Caused By An Injury, A Strain, Or A Muscle Weakness. The Most Common Hernias Are Inguinal Hernias, Which Occur In The Groin Area. Herniorrhaphy Involves Surgically Repairing The Hernia, Usually By Sewing The Defect In The Abdominal Wall Closed With Stitches. The Procedure May Also Involve The Use Of A Mesh To Reinforce The Repair. In Some Cases, The Hernia May Be Treated With A Procedure Called A Laparoscopic Hernia Repair, In Which A Camera And Instruments Are Inserted Through Small Incisions In The Abdomen To Repair The Hernia. The Procedure Is Usually Done Under General Anesthesia And Takes About An Hour. After The Procedure, The Patient May Need To Stay In The Hospital For A Few Days. Recovery Time Varies, But Patients Typically Return To Normal Activities Within A Few Weeks. Complications Of Herniorrhaphy Are Rare, But Can Include Infection, Bleeding, And Pain. After The Procedure, The Patient Should Be Mindful Of Any Signs Of Infection, Such As Fever, Redness, Or Swelling Around The Incision Site. Overall, Herniorrhaphy Is A Safe, Relatively Quick, And Effective Way To Repair Hernias And To Reduce The Risk Of Further Complications. With The Proper Care And Precautions, Most People Who Undergo The Procedure Experience No Long-Term Problems And Return To Their Normal Activities Quickly.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States